EA014070B1 - Применение растительной композиции для лечения воспалительных нарушений - Google Patents
Применение растительной композиции для лечения воспалительных нарушений Download PDFInfo
- Publication number
- EA014070B1 EA014070B1 EA200800850A EA200800850A EA014070B1 EA 014070 B1 EA014070 B1 EA 014070B1 EA 200800850 A EA200800850 A EA 200800850A EA 200800850 A EA200800850 A EA 200800850A EA 014070 B1 EA014070 B1 EA 014070B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- extract
- inflammatory disorder
- composition
- compound
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1226MU2005 | 2005-09-30 | ||
| US73644305P | 2005-11-14 | 2005-11-14 | |
| PCT/IB2006/053540 WO2007036900A2 (en) | 2005-09-30 | 2006-09-28 | Herbal composition for inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200800850A1 EA200800850A1 (ru) | 2008-10-30 |
| EA014070B1 true EA014070B1 (ru) | 2010-08-30 |
Family
ID=37900158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200800850A EA014070B1 (ru) | 2005-09-30 | 2006-09-28 | Применение растительной композиции для лечения воспалительных нарушений |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7635494B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1931366B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5331962B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006296197B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2624049C (cg-RX-API-DMAC7.html) |
| EA (1) | EA014070B1 (cg-RX-API-DMAC7.html) |
| GE (1) | GEP20115332B (cg-RX-API-DMAC7.html) |
| MA (1) | MA29890B1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1931366T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007036900A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8981131B2 (en) * | 2007-07-27 | 2015-03-17 | Piramal Enterprises Limited | Tricyclic compounds for the treatment of inflammatory disorders |
| WO2009084032A2 (en) * | 2007-12-03 | 2009-07-09 | Vedic Elements Private Limited | Stable hydrophobic topical herbal formulation |
| WO2012014216A1 (en) * | 2010-07-28 | 2012-02-02 | Laila Nutraceuticals | 7-hydroxyfrullanolide and its analogs for prevention, control and treatment of metabolic disorders |
| US10105347B2 (en) | 2009-02-02 | 2018-10-23 | Laila Nutraceuticals | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels |
| CN102292093B (zh) * | 2009-02-02 | 2015-01-28 | 莱拉营养食品有限公司 | 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物 |
| WO2011033524A2 (en) * | 2009-08-04 | 2011-03-24 | Laila Nutraceuticals | Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases |
| WO2011083397A1 (en) * | 2010-01-05 | 2011-07-14 | Himalaya Global Holdings Limited | Herbal composition for skin disorders |
| PH12013500451A1 (en) * | 2010-09-11 | 2013-05-20 | Laila Nutraceuticals | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels |
| US8263579B2 (en) * | 2011-01-24 | 2012-09-11 | Piramal Healthcare Limited | Anti-inflammatory compounds |
| TW201427677A (zh) * | 2012-10-23 | 2014-07-16 | Piramal Entpr Ltd | 用於預防及治療腫瘤壞死因子-α媒介疾病中藥組合物 |
| EP3313384A4 (en) | 2015-06-23 | 2019-04-03 | Nobilis Therapeutics, Inc. | THERAPEUTIC IMMUNE MODULATION USING NOBLE GAS COMPOSITIONS |
| WO2017203540A1 (en) * | 2016-05-21 | 2017-11-30 | Laila Impex | Dietary supplements and compositions for enhancing physical performance and energy levels |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006016228A2 (en) * | 2004-08-02 | 2006-02-16 | Prashanth Kumar V | Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646687A (en) * | 1994-12-29 | 1997-07-08 | Lucent Technologies Inc. | Temporally-pipelined predictive encoder/decoder circuit and method |
| US6204523B1 (en) * | 1998-11-06 | 2001-03-20 | Lumileds Lighting, U.S., Llc | High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range |
| US6686676B2 (en) * | 2001-04-30 | 2004-02-03 | General Electric Company | UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same |
| US6989412B2 (en) * | 2001-06-06 | 2006-01-24 | Henkel Corporation | Epoxy molding compounds containing phosphor and process for preparing such compositions |
| US6841647B2 (en) * | 2001-11-06 | 2005-01-11 | National Starch And Chemical Investment Holding Corporation | Fluid resistant silicone encapsulant |
| US7160972B2 (en) * | 2003-02-19 | 2007-01-09 | Nusil Technology Llc | Optically clear high temperature resistant silicone polymers of high refractive index |
| US7261441B2 (en) * | 2004-02-27 | 2007-08-28 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | LED device and method for directing LED light |
| US7229934B2 (en) * | 2004-10-18 | 2007-06-12 | International Business Machines Corporation | Porous organosilicates with improved mechanical properties |
-
2006
- 2006-09-28 AU AU2006296197A patent/AU2006296197B2/en not_active Ceased
- 2006-09-28 PL PL06809434T patent/PL1931366T3/pl unknown
- 2006-09-28 WO PCT/IB2006/053540 patent/WO2007036900A2/en not_active Ceased
- 2006-09-28 CA CA2624049A patent/CA2624049C/en active Active
- 2006-09-28 GE GEAP200610647A patent/GEP20115332B/en unknown
- 2006-09-28 EA EA200800850A patent/EA014070B1/ru active IP Right Revival
- 2006-09-28 JP JP2008532961A patent/JP5331962B2/ja not_active Expired - Fee Related
- 2006-09-28 EP EP06809434.1A patent/EP1931366B1/en active Active
-
2008
- 2008-03-28 US US12/079,853 patent/US7635494B2/en active Active
- 2008-04-29 MA MA30886A patent/MA29890B1/fr unknown
-
2009
- 2009-07-09 US US12/500,057 patent/US8206756B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006016228A2 (en) * | 2004-08-02 | 2006-02-16 | Prashanth Kumar V | Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases |
Non-Patent Citations (4)
| Title |
|---|
| ATTA-UR-RAHMAN ET AL. "7 HYDROXYFRULLANOLIDE AN ANTIMICROBIAL SESQUITERPENE LACTONE FROM SPHAERANTHUS-INDICUS LINN", JOURNAL OF CHEMICAL RESEARCH (SYNOPSES), no. 3, 1989, page 68, XP009082614, ISSN: 0308-2342, paragraph [0001]; compound 1 * |
| BAFNA A.R. ET AL. "Immunomodulatory activity of methanol extract of flower-heads of Sphaeranthus indicus Linn", ARS PHARMACEUTICA 2004 SPAIN, vol. 45, no. 3, 2004, pages 281-291, XP009082652, ISSN: 0004-2927, page 282, right-hand column, paragraph 3, page 283, right-hand column, paragraph 1, page 287, right-hand column, paragraph 2; tab. 1 * |
| GOGTE M.G. ET AL. "SOME INTERESTING SESQUITERPENOIDS FROM SPHAERANTHUS-INDICUS COMPOSITAE", INDIAN JOURNAL OF CHEMISTRY SECTION B ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, vol. 25, no. 3, 1986, pages 233-238, XP009082613, ISSN: 0376-4699, page 236, left-hand column, paragraph 6 - right-hand column, paragraph 3; compounds 1, 2 * |
| JAIN A. ET AL. "Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs", PHYTOMEDICINE, GUSTAV FISCHER VERLAG, STUTTGART, DE, vol. 10, no. 1, 2003, pages 34-38, XP004957198, ISSN: 0944-7113, abstract, page 36, left-hand column, paragraph 3; tab. 1, 2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2624049A1 (en) | 2007-04-05 |
| WO2007036900A2 (en) | 2007-04-05 |
| HK1112418A1 (en) | 2008-09-05 |
| CA2624049C (en) | 2016-01-12 |
| AU2006296197A2 (en) | 2008-06-05 |
| MA29890B1 (fr) | 2008-10-03 |
| AU2006296197A1 (en) | 2007-04-05 |
| US7635494B2 (en) | 2009-12-22 |
| US20090269427A1 (en) | 2009-10-29 |
| JP5331962B2 (ja) | 2013-10-30 |
| JP2009510051A (ja) | 2009-03-12 |
| EA200800850A1 (ru) | 2008-10-30 |
| US20080254157A1 (en) | 2008-10-16 |
| AU2006296197B2 (en) | 2012-08-09 |
| PL1931366T3 (pl) | 2013-11-29 |
| US8206756B2 (en) | 2012-06-26 |
| GEP20115332B (en) | 2011-11-25 |
| WO2007036900A3 (en) | 2007-08-02 |
| EP1931366B1 (en) | 2013-05-29 |
| EP1931366A2 (en) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8206756B2 (en) | Herbal composition for inflammatory disorders | |
| KR101285234B1 (ko) | 백미 추출물을 포함하는 관절염 예방 및 치료용 조성물 | |
| AU2022201835B2 (en) | Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders | |
| ES2426174T3 (es) | Composición herbácea para trastornos inflamatorios | |
| JP5086805B2 (ja) | 「抗ガン性野生チョウセンニンジンの精製エキス調整法及びそのガン融合製剤」 | |
| US7862837B2 (en) | Herbal composition | |
| KR20220168960A (ko) | 감초 신품종 원감 또는 신원감을 포함하는 알레르기에 치료 및 예방에 효과있는 약제학적 조성물 및 그 치료제 | |
| KR20000026053A (ko) | 류코트리엔 생성 저해활성을 가지는 신이 추출물 및 신이로부터분리한 리그난 화합물 | |
| CN113230255A (zh) | 阿帕替尼在制备防治nlrp3炎症小体相关疾病的药物中的应用 | |
| ES2241182T3 (es) | Procedimiento de inhibicion de la produccion de citocinas. | |
| KR101606645B1 (ko) | 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물 | |
| KR20240041837A (ko) | 귤핵 추출물을 포함하는 미세먼지로 유발된 질환의 예방, 개선 또는 치료용 조성물 및 이의 용도 | |
| KR100355497B1 (ko) | 류코트리엔생성저해활성을가지는정유성분 | |
| JPH09506635A (ja) | インターロイキン−6の生産を阻害するステファニアテトランドラの抽出物 | |
| HK1112418B (en) | Herbal composition for inflammatory disorders | |
| JPH01500037A (ja) | Kbblのガン治療用途 | |
| Henri et al. | Effects of Cola anomala (K. Schum.) water/ethanol pods extract on the inflammation and intestinal secretion in lipopolysaccharide-induced diarrhea. | |
| MX2008004291A (es) | Composicion herbaria para trastornos inflamatorios | |
| KR20240003190A (ko) | 신주락톤 a를 포함하는 혈관 염증 치료용 조성물 | |
| JP2001316260A (ja) | カバラクトン類を有効成分とするTNF−α産生抑制剤 | |
| CN112933097A (zh) | 医药组合物用于制备促发炎细胞介素抑制剂的用途 | |
| JPH09100294A (ja) | 血管新生阻害剤 | |
| KR20200109499A (ko) | 진교 추출물을 포함하는 골 질환 예방 또는 치료용 조성물 | |
| KR20090104373A (ko) | 건강 추출물 또는 이로부터 분리된 활성 성분을 포함하는소염, 국소적 부종 경감, 수술 또는 타박상으로부터의 회복촉진, 또는 심장 질환의 치료 또는 예방을 위한 조성물 | |
| CN106924267A (zh) | 箭根薯酮内酯b在制备抗肿瘤药物增敏剂中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| TC4A | Change in name of a patent proprietor in a eurasian patent | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
| NF4A | Restoration of lapsed right to a eurasian patent |
Designated state(s): AM AZ BY KZ KG TJ TM |